These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6375887)

  • 1. Detection and quantification of mitoxantrone in human organs. A case report.
    Roboz J; Paciucci PA; Silides D; Greaves J; Holland JF
    Cancer Chemother Pharmacol; 1984; 13(1):67-8. PubMed ID: 6375887
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitoxantrone.
    Nathanson L
    Cancer Treat Rev; 1984 Dec; 11(4):289-93. PubMed ID: 6534511
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacokinetics and metabolism of mitoxantrone in man.
    Ehninger G; Proksch B; Heinzel G; Schiller E; Weible KH; Woodward DL
    Invest New Drugs; 1985; 3(2):109-16. PubMed ID: 4019115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatography.
    Ehninger G; Proksch B; Schiller E
    J Chromatogr; 1985 Jul; 342(1):119-27. PubMed ID: 4044741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of mitoxantrone: mode of action and pharmacokinetics.
    Alberts DS; Peng YM; Bowden GT; Dalton WS; Mackel C
    Invest New Drugs; 1985; 3(2):101-7. PubMed ID: 4040505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition of mitoxantrone in cancer patients.
    Alberts DS; Peng YM; Leigh S; Davis TP; Woodward DL
    Cancer Res; 1985 Apr; 45(4):1879-84. PubMed ID: 3978648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of mitoxantrone in patients.
    Alberts DS; Peng YM; Leigh S; Davis TP; Woodward DL
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():23-7. PubMed ID: 6661732
    [No Abstract]   [Full Text] [Related]  

  • 8. Drugs recently released in Belgium: mitoxantrone, gemfibrozil.
    Harvengt C
    Acta Clin Belg; 1986; 41(2):127-30. PubMed ID: 3463107
    [No Abstract]   [Full Text] [Related]  

  • 9. Improved high-performance liquid chromatography of the new antineoplastic agents bisantrene and mitoxantrone.
    Peng YM; Ormberg D; Alberts DS; Davis TP
    J Chromatogr; 1982 Dec; 233():235-47. PubMed ID: 7161336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic sarcomas with mitoxantrone.
    Presant CA; Gams R; Bartolucci AA
    Cancer Treat Rep; 1984 May; 68(5):813-4. PubMed ID: 6722837
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological disposition of 1,4-dihydroxy-5-8-bis[[2 [(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione dihydrochloride in the dog.
    Lu K; Savaraj N; Loo TL
    Cancer Chemother Pharmacol; 1984; 13(1):63-6. PubMed ID: 6733844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of mitoxantrone in the treatment of tumors].
    Klener P
    Cas Lek Cesk; 1984 Jul; 123(28):873. PubMed ID: 6488260
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
    Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
    Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitoxantrone in malignant melanoma.
    Presant CA; Gams R; Bartolucci A
    Cancer Treat Rep; 1984 Jun; 68(6):903-5. PubMed ID: 6733704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitoxantrone--a critique.
    Holland JF
    Cancer Treat Rev; 1983 Dec; 10 Suppl B():77-9. PubMed ID: 6661738
    [No Abstract]   [Full Text] [Related]  

  • 17. [Phase II study of mitoxantrone for hematologic malignancies].
    Ueoka H; Ueno K; Yamane T; Toyoda K; Endo H; Nishihara R; Takahashi I; Ohnoshi T; Kitajima K; Kimura I
    Gan To Kagaku Ryoho; 1983 Nov; 10(11):2399-402. PubMed ID: 6639101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of mitoxantrone.
    Anderson KC; Cohen GI; Garnick MB
    Cancer Treat Rep; 1982 Nov; 66(11):1929-31. PubMed ID: 7139638
    [No Abstract]   [Full Text] [Related]  

  • 19. The clinical pharmacology of mitozantrone.
    Smyth JF; Macpherson JS; Warrington PS; Leonard RC; Wolf CR
    Cancer Chemother Pharmacol; 1986; 17(2):149-52. PubMed ID: 3719894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mitoxantrone in the treatment of relapsed and refractory malignant lymphoma].
    Kimura I; Ohnoshi T; Hiraki S; Ueoka H; Toyata K; Miyamoto H; Yamane T; Ueno K; Murashima M
    Gan No Rinsho; 1985 May; 31(6 Suppl):767-73. PubMed ID: 4040985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.